WWG Stock Hunter — September 29, 2026 — Premarket Scan

Market status — 7:27 AM ET: This is a premarket scan, so prices and volume can change quickly before and after the opening bell. The goal is to rank where to look, then wait for confirmation rather than chase a headline.

1) SMMT — WATCH. Catalyst: AstraZeneca announced a $2 billion strategic equity investment in Summit Therapeutics at an effective $18.36 per share, with planned ivonescimab combination trials. The verified scan showed SMMT roughly 17%–18% higher near $18.10–$18.30 on heavy volume. Key level: the $18.36 transaction price. Support: $18.00–$18.36, then about $17, then the $15.48 prior close. Resistance: about $18.40–$18.50, then the $20 area. Bull case: outside validation and a stronger balance sheet. Bear case: traders mistake an equity investment for an acquisition and overprice the headline. Kill switch: price loses VWAP and cannot reclaim about $18.

2) FICO — WATCH, bearish bias but oversold. Catalyst: an FHFA mortgage-pricing change brings competing VantageScore into the Fannie Mae and Freddie Mac pricing framework. The verified scan showed FICO roughly 10%–13% lower premarket. Prior context: close about $841.44; 20-day average about $1,016; 50-day about $1,099; 200-day about $1,256; RSI around 30–35. Bull case: an oversold short-covering bounce. Bear case: lasting pressure on FICO’s moat and pricing power. Kill switch for the bearish setup: a strong VWAP reclaim followed by a higher low.

3) NVDA — WATCH. Catalyst: NVIDIA added $150 billion to its share-repurchase authorization, leaving about $235 billion authorized through fiscal 2028, alongside continued strength in AI infrastructure. The verified scan showed NVDA roughly 0.7%–1% higher premarket. Prior context: close $228.86; 20-day average about $222.30; 50-day about $216.50; 200-day about $199.70; RSI about 58.7. Support: $225, then $223, then $221–$222. Resistance: about $230.36, then $235–$236. Kill switch: sustained VWAP loss and failure to reclaim about $225.

4) MDB — WATCH / WAIT. Catalyst: MongoDB CEO Chirantan Desai left to lead Meta’s enterprise-AI platform. MongoDB reaffirmed its third-quarter and full-year fiscal 2027 guidance, and former CEO Dev Ittycheria returned as interim CEO. Investor Day is scheduled today from 11:00 AM to 3:30 PM ET. Monday’s move was about 17%–18% lower. Support: about $323–$325. Resistance: about $340–$350, then about $378. Bull case: intact guidance plus reassuring management commentary. Bear case: strategic uncertainty after another leadership change. Kill switch for a reversal long: $323 breaks and cannot be reclaimed.

5) BA — WAIT. Catalyst: the FAA paused 737 MAX 10 certification because of a newly disclosed software issue. Boeing fell about 6.9% Monday to $184.39 and was near $185 in the verified morning scan. RSI was about 27.5, an oversold reading that does not guarantee a bounce. Support: about $184 and Monday’s low. Resistance: about $190, then $197–$198. Bull case: the software fix proves short-lived and sellers exhaust. Bear case: certification uncertainty lasts longer. Kill switch for a reversal long: Monday’s low breaks on expanding volume.

Top setup to investigate first — SMMT. Confirmation sequence: the $18.00–$18.36 area holds; a pullback holds or reclaims VWAP; price makes a higher low; then the opening range or premarket high breaks with volume. If it gaps vertically without building a base, WAIT. If it loses VWAP and stays under $18, WAIT.

Catalyst detection tells you where to look; it is not a recommendation to enter a trade.

The same headline can produce very different outcomes depending on liquidity, volume, positioning and how price behaves around VWAP and key levels.

Options can lose 100% of premium. Define risk before entry and avoid treating an oversold reading or a large premarket move as proof of reversal or continuation.

A catalyst creates attention, not an automatic entry. Stock Hunter separates the news event from the trade decision: catalyst first, then liquidity, price, volume, VWAP, structure and risk control.

Transaction prices, policy changes, buybacks, management transitions and certification delays affect different parts of a company’s story. They should not be treated as interchangeable signals.

Educational use only. This scan is general market education, not personalized financial advice or a promise of profits or returns.

• SMMT: Summit and AstraZeneca announced the $2 billion preferred-equity investment at an $18.36 common-share equivalent and combination-trial plans; Reuters reported the terms and the $15.48 prior close.
• FICO: FHFA materials document broader VantageScore use in the Fannie Mae and Freddie Mac system; Reuters has reported the regulator’s expansion of VantageScore access and scrutiny of credit-score pricing.
• NVDA: NVIDIA announced the additional $150 billion authorization; Reuters reported that remaining authorization rose to about $235 billion through fiscal 2028.
• MDB: MongoDB announced Desai’s departure, Ittycheria’s interim return, reaffirmed guidance and Investor Day timing; Reuters reported Desai’s move to Meta and the market reaction.
• BA: Reuters reported that the FAA would delay MAX 10 certification until the newly disclosed software issue is resolved. Premarket prices, moving averages, RSI, VWAP references and levels are time-sensitive observations from the 7:27 AM ET verified scan supplied for this issue.

• Summit Therapeutics / AstraZeneca — $2 billion investment, $18.36 common-share equivalent and planned ivonescimab combination trials.
• Reuters — Summit Therapeutics / AstraZeneca — Investment terms, prior close and initial market reaction.
• FHFA — Official credit-score policy and expanded VantageScore availability for Fannie Mae and Freddie Mac lenders.
• Reuters — FHFA / VantageScore — Expansion of VantageScore use across approved lenders.
• NVIDIA — $150 billion authorization increase and $235 billion remaining through fiscal 2028.
• Reuters — NVIDIA — Buyback authorization and AI-infrastructure context.
• MongoDB — CEO transition, reaffirmed guidance and Investor Day schedule.
• Reuters — MongoDB / Meta — Desai’s move to Meta, interim leadership and market reaction.
• Reuters — FAA / Boeing — MAX 10 certification delay, software issue and Boeing market reaction.